J. Safra Asset Management’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.8M | Buy |
271,620
+4,566
| +2% | +$399K | 1.72% | 16 |
|
|
2025
Q1 | $24.3M | Buy |
267,054
+6,787
| +3% | +$618K | 2.03% | 16 |
|
|
2024
Q4 | $22.4M | Buy |
260,267
+181,511
| +230% | +$15.6M | 1.82% | 17 |
|
|
2024
Q3 | $7.47M | Buy |
78,756
+5,147
| +7% | +$488K | 0.71% | 19 |
|
|
2024
Q2 | $6.73M | Buy |
73,609
+4,084
| +6% | +$374K | 0.68% | 19 |
|
|
2024
Q1 | $6.31M | Buy |
+69,525
| New | +$6.31M | 0.71% | 18 |
|